Company profile
Cancer Research and Biotechnology company profile
Cancer Research and Biotechnology AG is a Swiss preclinical biopharma company focused on developing treatments for cancer and other degenerative diseases. The company is dedicated to creating safe and efficient drugs, with a particular emphasis on aggressive cancers. One of their key developments includes CRB091, a drug targeted against Triple Negative Breast Cancer. Their research and development efforts aim to advance the understanding and treatment of various cancer types, contributing to the broader field of oncology.
Business identity
- Website
- https://www.crab.ch
- Contact email
- [email protected]
- Phone number
- +41 41 510 01 34
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $1M-$10M
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- Baar, Zug, Switzerland
- Postal code
- 6340
- Country code
- CH
- Continent
- Europe